Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
ID: 345794Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/345794

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-077.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a Collaborative Program Grant (RM1) to support multidisciplinary research teams focused on addressing complex biomedical questions aligned with the mission of the National Institute of General Medical Sciences (NIGMS). Each team, consisting of three to six Program Directors/Principal Investigators (PDs/PIs), must demonstrate a cohesive approach to achieve significant scientific advancements that cannot be accomplished through individual efforts. This funding opportunity emphasizes the importance of diversity in research, requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity in team composition and project goals. Funding is available for up to five years, with requests of up to $1.5 million in direct costs per year, and the NIH anticipates awarding 4 to 6 grants per fiscal year based on application quality and available funding. Interested applicants can find more information and application guidelines at the NIH website and should direct inquiries to grantsinfo@nih.gov. The application deadline is January 27, 2026.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-077-Full-Announcement.html
    PAR-23-077.html
    The National Institutes of Health (NIH) is offering a Collaborative Program Grant (RM1) to support multidisciplinary research teams aimed at addressing complex biomedical questions within the mission of the National Institute of General Medical Sciences (NIGMS). Each team, consisting of three to six Program Directors/Principal Investigators (PDs/PIs), must demonstrate a cohesive approach to achieve significant scientific advancements that individual projects could not. This funding opportunity emphasizes the importance of diversity in research, requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity in team composition and project goals. Successful applications should propose innovative research programs, with funding available for up to five years, allowing for requests of up to $1.5 million in direct costs per year. The NIH anticipates providing 4 to 6 awards per fiscal year, contingent on the quality of applications and available funding. Interested institutions must adhere to rigorous application guidelines and maintain various registrations, ensuring compliance with all eligibility requirements. This initiative reflects NIH's commitment to fostering collaborative efforts in advancing biomedical research, particularly through diverse and integrated scientific approaches.
    Similar Opportunities
    NINDS Program Project Grant (P01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke (NINDS), is offering the Program Project Grant (P01) to support innovative, collaborative research addressing significant scientific questions within its mission. This grant encourages multi-disciplinary projects that are interdependent, allowing for greater scientific advancements than individual efforts, and applications may include clinical trials, although those focused on intervention effectiveness should seek different funding opportunities. Eligible applicants include higher education institutions, nonprofits, and governmental entities, with funding of up to $1 million in direct costs per year available for a maximum project period of five years. Interested parties should consult with NINDS staff early in the proposal process, with the application submission period opening on April 25, 2024, and due by May 25, 2024; for further inquiries, contact grantsinfo@nih.gov.
    NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is inviting applications for Program Project Grants (P01 Clinical Trial Optional) aimed at fostering collaborative, multidisciplinary research on substance use disorders. Applicants must propose a minimum of three interrelated research projects that demonstrate scientific and administrative synergy under a unifying theme, addressing critical issues such as neuroscience, genetics, behavior, prevention, treatment, and health services related to substance use. This funding opportunity emphasizes inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) and encouraging participation from underrepresented groups, with a maximum project duration of five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by January 7, 2026.
    Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE)," aimed at fostering interdisciplinary research teams to address complex neuroscience challenges. This initiative supports collaborative efforts involving three to six principal investigators (PIs) who must present a cohesive research plan with a singular focus, emphasizing team integration and transformative objectives over a five-year period. The NIH plans to allocate up to $10 million annually for 4-6 awards, with individual project budgets ranging from $500,000 to $1.5 million. Applications are due by October 8, 2024, and interested parties can find more information and application guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Centers of Excellence in Genomic Science (CEGS) program, aimed at supporting innovative, interdisciplinary research in genomic science. This program seeks to establish academic centers that will develop transformative genomic approaches to address significant biomedical challenges, with a focus on integrating advanced technological and computational methods. Each award can provide up to $1.5 million per year for a maximum of five years, with potential renewal for an additional five years, and applications are due by June 23, 2025. Eligible applicants include a range of institutions such as higher education entities, nonprofits, and various government organizations, while foreign entities are not eligible. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Dental and Craniofacial Research (NIDCR), is offering a funding opportunity titled "Collaborative Science to Achieve Disruptive Innovations in Dental, Oral, and Craniofacial (DOC) Research." This initiative aims to support highly integrated research teams that address significant challenges in the DOC fields through collaborative science, requiring a transdisciplinary approach with three to six principal investigators and a detailed Team Management Plan. The program emphasizes the importance of fostering team science to advance critical research in dental and oral health, with funding available of up to $750,000 per year for a maximum of five years, totaling approximately $3 million annually. Interested applicants can find more information and application details on the NIH website, with a submission deadline of November 19, 2024, and inquiries directed to grantsinfo@nih.gov.
    Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Opportunities for New and 'At-Risk' Investigators to Promote Workforce Diversity" (PAR-22-181), aimed at enhancing the diversity of the biomedical research workforce. This initiative invites R01 grant applications for independent research projects that align with the scientific missions of participating NIH Institutes or Centers, specifically targeting New Investigators and At-Risk Investigators from underrepresented backgrounds, including racial and ethnic minorities and individuals with disabilities. The program emphasizes the importance of addressing health disparities and promoting diverse representation in science, with funding allocations of up to $10 million for NINDS and $5 million for NIDA/NIMH, among others, for a maximum project period of five years. Interested applicants should submit their proposals by June 6, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Medical Scientist Partnership Program (MSPP), a federal grant aimed at developing a diverse pool of predoctoral students pursuing combined doctoral degrees (e.g., M.D./Ph.D.) within the NIH Intramural Research Program. The program seeks to provide rigorous training in biomedical sciences, emphasizing research study design, critical thinking, and professional development, with participants receiving mentorship and networking opportunities to prepare them for leadership roles in biomedical careers. This initiative is crucial for enhancing the biomedical workforce by cultivating clinician-scientists equipped with essential skills, with applications due by August 8, 2025. Interested applicants can find more information and application guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health, through the National Cancer Institute (NCI), invites applications for Program Project grants (P01) aimed at fostering collaborative, multidisciplinary cancer research for the years 2023, 2024, and 2025. Applicants must propose at least three interrelated research projects and an Administrative Core, all centered around a common theme within the expansive field of cancer research, which includes areas such as cancer biology, prevention, diagnosis, treatment, and control. This funding opportunity is crucial for advancing cancer research and enhancing the effectiveness of collaborative efforts, with applications due by May 7, 2026. Interested parties can find more information and application guidelines at the provided link, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) to support a broad program of research within the mission of the National Institute of General Medical Sciences (NIGMS). This grant aims to enhance the efficiency and efficacy of funding by providing stability and flexibility to investigators, allowing them to pursue diverse scientific inquiries over a five-year term, with funding levels capped at $750,000 in direct costs per year and typically set at $250,000 for New Investigators. The MIRA program is designed to reduce the application burden on researchers, encourage innovation, and foster diversity in the research workforce, with applications undergoing a rigorous peer review process. Interested applicants must submit their proposals by May 16, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.